Figure 1.

EHF is highly expressed in multiple cancers. (a) qRT-PCR assay was performed to evaluate mRNA expression of EHF in primary gastric cancers (T) and their matched non-cancerous gastric tissues (N; n=30), gliomas (G; n=18) and meningiomas (M; n=19), primary lung cancers (T) and their matched non-cancerous tissues (N; n=18), as well as primary thyroid cancers (T) and their matched non-cancerous tissues (N; n=20), respectively. EHF expression was normalized with 18S rRNA levels. (b) High expression of EHF in gastric cancers (T) compared with normal gastric tissues (N) in TCGA data set. Horizontal lines indicate the median. (c) Significant correlation between EHF expression and the survival of gastric cancer patients in the Kaplan–Meier Plotter database